Aviado · Research
Longevity Daily
Tuesday, June 2, 2026
Listen
Today's Brief
Today's stories coalesce around a central theme: how wide is the gap between your chronological age and how your body actually functions. New research in Neurology — today's must-read — finds that cognitive and brain reserve may actively buffer against Alzheimer's pathology, giving you a powerful reason to keep learning and staying mentally engaged. A landmark Aging Cell study introduces a noninvasive Liver Aging Index that outperforms chronological age in predicting mortality, while a UK study of 3,556 adults confirms that arts engagement slows epigenetic aging independently of exercise. New evidence also challenges the assumption that antioxidant supplements are universally beneficial.
10 stories5 peer-reviewed1 trials
Cognitive Health & Neuroprotection
Building Brain Reserve May Buffer the Cognitive Effects of Alzheimer's Disease
New research published in Neurology finds that greater cognitive and brain reserve — built through education, mentally stimulating work, and rich social engagement — may meaningfully cushion the cognitive impact of underlying Alzheimer's pathology. In other words, even when amyloid and tau accumulate, people with higher reserve tend to function better for longer. This matters because it reframes brain-health investment not just as prevention but as active protection against neurodegeneration that may already be underway. The "use it and keep using it" model of brain resilience just got a significant evidence boost.
Read more →Supplements & Compounds
Antioxidant Supplements Before and During Chemotherapy Linked to 41% Higher Breast Cancer Recurrence Risk
A case study analysis in Pharmacy Times found a 41% increase in the hazard of breast cancer recurrence when patients used any antioxidant supplementation before and during chemotherapy treatment. The concern is mechanistically plausible: antioxidants may shield cancer cells from the oxidative damage that makes chemo effective, essentially blunting the treatment. If you or someone close to you is undergoing cancer therapy, this is a critical conversation to have with your oncologist before reaching for the supplement shelf.
Read more →Specific Supplements May Influence Menopause Timing, Large-Scale Study Suggests
One of the first large-scale analyses to examine supplementation and menopause timing finds that specific compounds — including glutathione, resveratrol, B vitamins, lycopene, and piperine — alongside lifestyle factors may be associated with when menopause occurs. The study is observational and does not prove cause and effect, but its scale makes it worth attention for women tracking ovarian health. Earlier or later menopause has meaningful downstream implications for cardiovascular risk and overall longevity trajectory.
Read more →Research & Papers
New Liver Aging Index Predicts Mortality Better Than Chronological Age
Researchers developed and validated the Liver Aging Index (LAI) — a noninvasive score built from routine blood biomarkers and imaging — across more than 37,000 people in three global cohorts. Each standard deviation of liver aging acceleration above chronological age was associated with a 22–85% higher risk of all-cause mortality, outperforming chronological age alone. Strikingly, genetic analysis linked accelerated liver aging to dramatically elevated risks of cirrhosis (HR 3.94) and liver cancer (HR 7.82), making proactive liver health monitoring a compelling and underappreciated longevity priority.
Read more →Longevity Science Is Pivoting Toward Wholesale Biological Replacement of Aging Tissues
A new Aging Cell perspective paper argues the longevity field is shifting from incremental molecular tweaks toward wholesale biological and synthetic replacement of aging cells, tissues, and organs — including mitochondria and genes. Drawing on findings from the inaugural Replacement in Aging workshop, the authors map a roadmap covering cell therapies, organ replacement, and systemic rejuvenation strategies. Still early-stage and largely preclinical, but this framing signals where serious longevity science investment is heading next.
Read more →Metformin Users Show 30% Lower Risk of Dying Before Age 90 Versus Sulfonylurea Users
A new analysis found that patients initiating metformin had a 30% lower risk of the "exceptional longevity" endpoint — defined as surviving to age 90 — compared to those taking sulfonylurea, a common diabetes drug class used as a comparison group. The finding adds to a growing body of observational evidence pointing toward metformin's off-target longevity potential. Note the limitations: this is observational, subject to the healthy-user effect, and reported by a general wellness outlet rather than a primary journal source — seek the original study for full methodology.
Read more →Lifestyle & Nutrition
Peter Attia's Sleep Pharmacology Deep Dive: Matching Medications to Your Specific Sleep Problems
Peter Attia's latest episode (ep. 394) covers the full pharmacology of sleep medications, emerging sleep therapies, and the evidence for common sleep supplements. The core insight: different drugs vary significantly in how quickly they act, how long they last, and which sleep architecture they target — making drug-problem matching far more important than one-size-fits-all prescribing. Essential listening for anyone treating sleep as a first-order longevity lever.
Read more →Arts Engagement Slows Epigenetic Aging Independently of Physical Activity, Study of 3,556 Adults Finds
Analysis of 3,556 UK adults found that arts and cultural engagement — museum visits, choir, creative pursuits — was independently associated with slower epigenetic aging, on top of the known benefit from physical activity. This is one of the few studies to cleanly separate the two exposures, confirming that arts engagement carries its own biological anti-aging signal beyond what exercise provides. Published in Innovation in Aging using data from the UK Household Longitudinal Study.
Read more →The CALERIE 2 Trial Confirms Surprising Benefits of 25% Calorie Reduction Beyond Weight Loss
Revisiting the CALERIE 2 randomized controlled trial — which enrolled 218 healthy adults without obesity and asked half to reduce calorie intake by 25% — new analysis confirms that the benefits extend well beyond weight management. The level of support participants received (extensive nutrition education) means results don't straightforwardly translate to casual meal skipping, but the findings reinforce intentional caloric moderation as a meaningful healthspan tool worth taking seriously.
Read more →Industry & Policy
Putin's $26 Billion Longevity Bet: Inside Russia's State-Backed Anti-Aging Program
Russia is running a state-backed $26 billion longevity program, with Putin personally engaged in anti-aging protocols. Wall Street Journal chief European correspondent Bojan Pancevski breaks down what's driving the investment and what it reveals about the emerging geopolitics of life extension. Whatever the scientific merit, the scale of national resources being mobilized signals that longevity has become a strategic priority well beyond Silicon Valley.
Read more →